#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1 .
1-1	0-1	1	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Introduction
2-1	4-16	Introduction	abstract	new	_	_

#Text=The devastating threat of antimicrobial resistance ( AMR ) to global human health is unquestionable .
3-1	17-20	The	abstract[3]	new[3]	_	_
3-2	21-32	devastating	abstract[3]	new[3]	_	_
3-3	33-39	threat	abstract[3]	new[3]	_	_
3-4	40-42	of	abstract[3]	new[3]	_	_
3-5	43-56	antimicrobial	abstract[3]|abstract[4]	new[3]|new[4]	coref	18-6[138_4]
3-6	57-67	resistance	abstract[3]|abstract[4]	new[3]|new[4]	_	_
3-7	68-69	(	abstract[3]	new[3]	_	_
3-8	70-73	AMR	abstract[3]|organization	new[3]|new	coref	4-16
3-9	74-75	)	abstract[3]	new[3]	_	_
3-10	76-78	to	abstract[3]	new[3]	_	_
3-11	79-85	global	abstract[3]|abstract[6]	new[3]|new[6]	coref	6-7[0_6]
3-12	86-91	human	abstract[3]|abstract[6]	new[3]|new[6]	_	_
3-13	92-98	health	abstract[3]|abstract[6]	new[3]|new[6]	_	_
3-14	99-101	is	_	_	_	_
3-15	102-116	unquestionable	_	_	_	_
3-16	117-118	.	_	_	_	_

#Text=Antimicrobials are losing their effectiveness in treating infections , due to the rapid emergence of AMR and the drying up of antimicrobial pipelines .
4-1	119-133	Antimicrobials	abstract	new	ana	4-4
4-2	134-137	are	_	_	_	_
4-3	138-144	losing	_	_	_	_
4-4	145-150	their	abstract|abstract[9]	giv|new[9]	coref|coref	7-15|7-15
4-5	151-164	effectiveness	abstract[9]	new[9]	_	_
4-6	165-167	in	_	_	_	_
4-7	168-176	treating	_	_	_	_
4-8	177-187	infections	abstract	new	coref	5-1[16_0]
4-9	188-189	,	_	_	_	_
4-10	190-193	due	_	_	_	_
4-11	194-196	to	_	_	_	_
4-12	197-200	the	event[11]	new[11]	_	_
4-13	201-206	rapid	event[11]	new[11]	_	_
4-14	207-216	emergence	event[11]	new[11]	_	_
4-15	217-219	of	event[11]	new[11]	_	_
4-16	220-223	AMR	event[11]|event	new[11]|giv	coref	5-3
4-17	224-227	and	event[11]	new[11]	_	_
4-18	228-231	the	event[11]|event[13]	new[11]|new[13]	_	_
4-19	232-238	drying	event[11]|event[13]	new[11]|new[13]	_	_
4-20	239-241	up	event[11]|event[13]	new[11]|new[13]	_	_
4-21	242-244	of	event[11]|event[13]	new[11]|new[13]	_	_
4-22	245-258	antimicrobial	event[11]|event[13]|object[14]	new[11]|new[13]|new[14]	_	_
4-23	259-268	pipelines	event[11]|event[13]|object[14]	new[11]|new[13]|new[14]	_	_
4-24	269-270	.	_	_	_	_

#Text=The difficult-to-treat AMR infections require longer hospital stays and more costly treatment , increase morbidity and mortality , and reduce productivity ; therefore , increasing the economic burden of the countries .
5-1	271-274	The	abstract[16]	giv[16]	coref	10-10[53_16]
5-2	275-293	difficult-to-treat	abstract[16]	giv[16]	_	_
5-3	294-297	AMR	organization|abstract[16]	giv|giv[16]	coref	7-6
5-4	298-308	infections	abstract[16]	giv[16]	_	_
5-5	309-316	require	_	_	_	_
5-6	317-323	longer	place[17]	new[17]	_	_
5-7	324-332	hospital	place[17]	new[17]	_	_
5-8	333-338	stays	_	_	_	_
5-9	339-342	and	_	_	_	_
5-10	343-347	more	abstract[18]	new[18]	_	_
5-11	348-354	costly	abstract[18]	new[18]	_	_
5-12	355-364	treatment	abstract[18]	new[18]	_	_
5-13	365-366	,	_	_	_	_
5-14	367-375	increase	_	_	_	_
5-15	376-385	morbidity	abstract	new	_	_
5-16	386-389	and	_	_	_	_
5-17	390-399	mortality	event	new	coref	14-14[101_0]
5-18	400-401	,	_	_	_	_
5-19	402-405	and	_	_	_	_
5-20	406-412	reduce	_	_	_	_
5-21	413-425	productivity	abstract	new	_	_
5-22	426-427	;	_	_	_	_
5-23	428-437	therefore	_	_	_	_
5-24	438-439	,	_	_	_	_
5-25	440-450	increasing	_	_	_	_
5-26	451-454	the	abstract[22]	new[22]	_	_
5-27	455-463	economic	abstract[22]	new[22]	_	_
5-28	464-470	burden	abstract[22]	new[22]	_	_
5-29	471-473	of	abstract[22]	new[22]	_	_
5-30	474-477	the	abstract[22]|place[23]	new[22]|new[23]	_	_
5-31	478-487	countries	abstract[22]|place[23]	new[22]|new[23]	_	_
5-32	488-489	.	_	_	_	_

#Text=In recent years , this global health crisis has been gaining much attention in Malaysia , and Malaysia has been striving hard to combat it via different approaches .
6-1	490-492	In	_	_	_	_
6-2	493-499	recent	time[24]	new[24]	_	_
6-3	500-505	years	time[24]	new[24]	_	_
6-4	506-507	,	_	_	_	_
6-5	508-512	this	abstract[26]	new[26]	coref	18-17[141_26]
6-6	513-519	global	abstract[26]	new[26]	_	_
6-7	520-526	health	abstract|abstract[26]	giv|new[26]	coref	16-11
6-8	527-533	crisis	abstract[26]	new[26]	_	_
6-9	534-537	has	_	_	_	_
6-10	538-542	been	_	_	_	_
6-11	543-550	gaining	_	_	_	_
6-12	551-555	much	abstract[27]	new[27]	ana	6-25[0_27]
6-13	556-565	attention	abstract[27]	new[27]	_	_
6-14	566-568	in	abstract[27]	new[27]	_	_
6-15	569-577	Malaysia	abstract[27]|place	new[27]|new	coref	6-18
6-16	578-579	,	_	_	_	_
6-17	580-583	and	_	_	_	_
6-18	584-592	Malaysia	place	giv	coref	28-21
6-19	593-596	has	_	_	_	_
6-20	597-601	been	_	_	_	_
6-21	602-610	striving	_	_	_	_
6-22	611-615	hard	_	_	_	_
6-23	616-618	to	_	_	_	_
6-24	619-625	combat	_	_	_	_
6-25	626-628	it	abstract	giv	_	_
6-26	629-632	via	_	_	_	_
6-27	633-642	different	abstract[31]	new[31]	_	_
6-28	643-653	approaches	abstract[31]	new[31]	_	_
6-29	654-655	.	_	_	_	_

#Text=The major contributing factors of AMR are known to be overuse and misuse of antimicrobials .
7-1	656-659	The	abstract[32]	new[32]	_	_
7-2	660-665	major	abstract[32]	new[32]	_	_
7-3	666-678	contributing	abstract[32]	new[32]	_	_
7-4	679-686	factors	abstract[32]	new[32]	_	_
7-5	687-689	of	abstract[32]	new[32]	_	_
7-6	690-693	AMR	abstract[32]|object	new[32]|giv	coref	11-21
7-7	694-697	are	_	_	_	_
7-8	698-703	known	_	_	_	_
7-9	704-706	to	_	_	_	_
7-10	707-709	be	_	_	_	_
7-11	710-717	overuse	abstract	new	coref	23-9[182_0]
7-12	718-721	and	_	_	_	_
7-13	722-728	misuse	abstract[35]	new[35]	_	_
7-14	729-731	of	abstract[35]	new[35]	_	_
7-15	732-746	antimicrobials	abstract[35]|substance	new[35]|giv	_	_
7-16	747-748	.	_	_	_	_

#Text=Antibiotic consumption by the elderly population was found to be between 11 % to 45 % , with a significant rise over the past decade .
8-1	749-759	Antibiotic	substance|abstract[38]	new|new[38]	coref|coref|coref|coref	9-9|12-4[81_38]|9-9|12-4[81_38]
8-2	760-771	consumption	abstract[38]	new[38]	_	_
8-3	772-774	by	abstract[38]	new[38]	_	_
8-4	775-778	the	abstract[38]|person[39]	new[38]|new[39]	coref	10-12[54_39]
8-5	779-786	elderly	abstract[38]|person[39]	new[38]|new[39]	_	_
8-6	787-797	population	abstract[38]|person[39]	new[38]|new[39]	_	_
8-7	798-801	was	_	_	_	_
8-8	802-807	found	_	_	_	_
8-9	808-810	to	_	_	_	_
8-10	811-813	be	_	_	_	_
8-11	814-821	between	_	_	_	_
8-12	822-824	11	quantity[40]	new[40]	coref	12-13[83_40]
8-13	825-826	%	quantity[40]	new[40]	_	_
8-14	827-829	to	quantity[40]	new[40]	_	_
8-15	830-832	45	quantity[40]|quantity[41]	new[40]|new[41]	_	_
8-16	833-834	%	quantity[40]|quantity[41]	new[40]|new[41]	_	_
8-17	835-836	,	_	_	_	_
8-18	837-841	with	_	_	_	_
8-19	842-843	a	event[42]	new[42]	_	_
8-20	844-855	significant	event[42]	new[42]	_	_
8-21	856-860	rise	event[42]	new[42]	_	_
8-22	861-865	over	event[42]	new[42]	_	_
8-23	866-869	the	event[42]|time[43]	new[42]|new[43]	_	_
8-24	870-874	past	event[42]|time[43]	new[42]|new[43]	_	_
8-25	875-881	decade	event[42]|time[43]	new[42]|new[43]	_	_
8-26	882-883	.	_	_	_	_

#Text=As much as 18 % of the total antibiotic prescriptions in older adults was unnecessary , with 54 % of them prescribed for acute respiratory conditions .
9-1	884-886	As	_	_	_	_
9-2	887-891	much	_	_	_	_
9-3	892-894	as	_	_	_	_
9-4	895-897	18	_	_	_	_
9-5	898-899	%	_	_	_	_
9-6	900-902	of	_	_	_	_
9-7	903-906	the	abstract[45]	new[45]	ana	9-21[0_45]
9-8	907-912	total	abstract[45]	new[45]	_	_
9-9	913-923	antibiotic	substance|abstract[45]	giv|new[45]	coref	17-6
9-10	924-937	prescriptions	abstract[45]	new[45]	_	_
9-11	938-940	in	abstract[45]	new[45]	_	_
9-12	941-946	older	abstract[45]|person[46]	new[45]|new[46]	coref	14-1[98_46]
9-13	947-953	adults	abstract[45]|person[46]	new[45]|new[46]	_	_
9-14	954-957	was	_	_	_	_
9-15	958-969	unnecessary	_	_	_	_
9-16	970-971	,	_	_	_	_
9-17	972-976	with	_	_	_	_
9-18	977-979	54	quantity[47]	new[47]	_	_
9-19	980-981	%	quantity[47]	new[47]	_	_
9-20	982-984	of	quantity[47]	new[47]	_	_
9-21	985-989	them	quantity[47]|abstract	new[47]|giv	coref	21-33
9-22	990-1000	prescribed	_	_	_	_
9-23	1001-1004	for	_	_	_	_
9-24	1005-1010	acute	abstract[49]	new[49]	_	_
9-25	1011-1022	respiratory	abstract[49]	new[49]	_	_
9-26	1023-1033	conditions	abstract[49]	new[49]	_	_
9-27	1034-1035	.	_	_	_	_

#Text=Healthcare providers face challenges in adequately diagnosing and managing infections in this vulnerable population because of the altered drug metabolism in this particular group , the common occurrence of drug â€“ drug interactions due to polypharmacy and lower medication adherence .
10-1	1036-1046	Healthcare	organization|person[51]	new|new[51]	_	_
10-2	1047-1056	providers	person[51]	new[51]	_	_
10-3	1057-1061	face	_	_	_	_
10-4	1062-1072	challenges	abstract	new	_	_
10-5	1073-1075	in	_	_	_	_
10-6	1076-1086	adequately	_	_	_	_
10-7	1087-1097	diagnosing	_	_	_	_
10-8	1098-1101	and	_	_	_	_
10-9	1102-1110	managing	_	_	_	_
10-10	1111-1121	infections	abstract[53]	giv[53]	coref	13-5[0_53]
10-11	1122-1124	in	abstract[53]	giv[53]	_	_
10-12	1125-1129	this	abstract[53]|person[54]	giv[53]|giv[54]	coref	13-9[90_54]
10-13	1130-1140	vulnerable	abstract[53]|person[54]	giv[53]|giv[54]	_	_
10-14	1141-1151	population	abstract[53]|person[54]	giv[53]|giv[54]	_	_
10-15	1152-1159	because	abstract[53]|person[54]	giv[53]|giv[54]	_	_
10-16	1160-1162	of	abstract[53]|person[54]	giv[53]|giv[54]	_	_
10-17	1163-1166	the	abstract[53]|person[54]|abstract[56]	giv[53]|giv[54]|new[56]	_	_
10-18	1167-1174	altered	abstract[53]|person[54]|abstract[56]	giv[53]|giv[54]|new[56]	_	_
10-19	1175-1179	drug	abstract[53]|person[54]|substance|abstract[56]	giv[53]|giv[54]|new|new[56]	coref	10-30
10-20	1180-1190	metabolism	abstract[53]|person[54]|abstract[56]	giv[53]|giv[54]|new[56]	_	_
10-21	1191-1193	in	abstract[53]|person[54]|abstract[56]	giv[53]|giv[54]|new[56]	_	_
10-22	1194-1198	this	abstract[53]|person[54]|abstract[56]|person[57]	giv[53]|giv[54]|new[56]|new[57]	_	_
10-23	1199-1209	particular	abstract[53]|person[54]|abstract[56]|person[57]	giv[53]|giv[54]|new[56]|new[57]	_	_
10-24	1210-1215	group	abstract[53]|person[54]|abstract[56]|person[57]	giv[53]|giv[54]|new[56]|new[57]	_	_
10-25	1216-1217	,	abstract[53]|person[54]	giv[53]|giv[54]	_	_
10-26	1218-1221	the	abstract[53]|person[54]|abstract[58]	giv[53]|giv[54]|new[58]	_	_
10-27	1222-1228	common	abstract[53]|person[54]|abstract[58]	giv[53]|giv[54]|new[58]	_	_
10-28	1229-1239	occurrence	abstract[53]|person[54]|abstract[58]	giv[53]|giv[54]|new[58]	_	_
10-29	1240-1242	of	abstract[53]|person[54]|abstract[58]	giv[53]|giv[54]|new[58]	_	_
10-30	1243-1247	drug	abstract[53]|person[54]|abstract[58]|substance	giv[53]|giv[54]|new[58]|giv	coref	10-32
10-31	1248-1249	â€“	_	_	_	_
10-32	1250-1254	drug	substance|abstract[61]	giv|new[61]	_	_
10-33	1255-1267	interactions	abstract[61]	new[61]	_	_
10-34	1268-1271	due	abstract[61]	new[61]	_	_
10-35	1272-1274	to	_	_	_	_
10-36	1275-1287	polypharmacy	abstract	new	_	_
10-37	1288-1291	and	_	_	_	_
10-38	1292-1297	lower	abstract[64]	new[64]	_	_
10-39	1298-1308	medication	substance|abstract[64]	new|new[64]	_	_
10-40	1309-1318	adherence	abstract[64]	new[64]	_	_
10-41	1319-1320	.	_	_	_	_

#Text=Nursing homes or long term care facilities in the United States and Australia were found to be a reservoir for AMR pathogens due to excessive , inappropriate and prolonged broad-spectrum antimicrobial use , inadequate infection control and increased risk of pathogen colonization .
11-1	1321-1328	Nursing	_	_	_	_
11-2	1329-1334	homes	place	new	coref	12-7[82_0]
11-3	1335-1337	or	_	_	_	_
11-4	1338-1342	long	place[67]	new[67]	_	_
11-5	1343-1347	term	place[67]	new[67]	_	_
11-6	1348-1352	care	abstract|place[67]	new|new[67]	_	_
11-7	1353-1363	facilities	place[67]	new[67]	_	_
11-8	1364-1366	in	place[67]	new[67]	_	_
11-9	1367-1370	the	place[67]|place[68]	new[67]|new[68]	coref	12-16[84_68]
11-10	1371-1377	United	place[67]|place[68]	new[67]|new[68]	_	_
11-11	1378-1384	States	place[67]|place[68]	new[67]|new[68]	_	_
11-12	1385-1388	and	place[67]	new[67]	_	_
11-13	1389-1398	Australia	place[67]|place	new[67]|new	_	_
11-14	1399-1403	were	_	_	_	_
11-15	1404-1409	found	_	_	_	_
11-16	1410-1412	to	_	_	_	_
11-17	1413-1415	be	_	_	_	_
11-18	1416-1417	a	abstract[70]	new[70]	_	_
11-19	1418-1427	reservoir	abstract[70]	new[70]	_	_
11-20	1428-1431	for	abstract[70]	new[70]	_	_
11-21	1432-1435	AMR	abstract[70]|organization|abstract[72]	new[70]|giv|new[72]	_	_
11-22	1436-1445	pathogens	abstract[70]|abstract[72]	new[70]|new[72]	_	_
11-23	1446-1449	due	abstract[70]|abstract[72]	new[70]|new[72]	_	_
11-24	1450-1452	to	abstract[70]|abstract[72]	new[70]|new[72]	_	_
11-25	1453-1462	excessive	abstract[70]|abstract[72]|abstract[73]|abstract[74]	new[70]|new[72]|new[73]|new[74]	coref|coref|coref|coref	12-29[87_73]|28-27[231_74]|12-29[87_73]|28-27[231_74]
11-26	1463-1464	,	abstract[70]|abstract[72]|abstract[73]|abstract[74]	new[70]|new[72]|new[73]|new[74]	_	_
11-27	1465-1478	inappropriate	abstract[70]|abstract[72]|abstract[73]|abstract[74]	new[70]|new[72]|new[73]|new[74]	_	_
11-28	1479-1482	and	abstract[70]|abstract[72]|abstract[73]|abstract[74]	new[70]|new[72]|new[73]|new[74]	_	_
11-29	1483-1492	prolonged	abstract[70]|abstract[72]|abstract[73]|abstract[74]	new[70]|new[72]|new[73]|new[74]	_	_
11-30	1493-1507	broad-spectrum	abstract[70]|abstract[72]|abstract[73]|abstract[74]	new[70]|new[72]|new[73]|new[74]	_	_
11-31	1508-1521	antimicrobial	abstract[70]|abstract[72]|abstract[73]|abstract[74]	new[70]|new[72]|new[73]|new[74]	_	_
11-32	1522-1525	use	abstract[70]|abstract[72]|abstract[73]|abstract[74]	new[70]|new[72]|new[73]|new[74]	_	_
11-33	1526-1527	,	abstract[70]|abstract[72]|abstract[74]	new[70]|new[72]|new[74]	_	_
11-34	1528-1538	inadequate	abstract[70]|abstract[72]|abstract[74]|abstract[76]	new[70]|new[72]|new[74]|new[76]	_	_
11-35	1539-1548	infection	abstract[70]|abstract[72]|abstract[74]|abstract|abstract[76]	new[70]|new[72]|new[74]|new|new[76]	_	_
11-36	1549-1556	control	abstract[70]|abstract[72]|abstract[74]|abstract[76]	new[70]|new[72]|new[74]|new[76]	_	_
11-37	1557-1560	and	abstract[70]|abstract[72]|abstract[74]	new[70]|new[72]|new[74]	_	_
11-38	1561-1570	increased	abstract[70]|abstract[72]|abstract[74]|abstract[77]	new[70]|new[72]|new[74]|new[77]	_	_
11-39	1571-1575	risk	abstract[70]|abstract[72]|abstract[74]|abstract[77]	new[70]|new[72]|new[74]|new[77]	_	_
11-40	1576-1578	of	abstract[70]|abstract[72]|abstract[74]|abstract[77]	new[70]|new[72]|new[74]|new[77]	_	_
11-41	1579-1587	pathogen	abstract[70]|abstract[72]|abstract[74]|abstract[77]|place|abstract[79]	new[70]|new[72]|new[74]|new[77]|new|new[79]	_	_
11-42	1588-1600	colonization	abstract[70]|abstract[72]|abstract[74]|abstract[77]|abstract[79]	new[70]|new[72]|new[74]|new[77]|new[79]	_	_
11-43	1601-1602	.	_	_	_	_

#Text=The prevalence of antimicrobial consumption in nursing homes was reported to be 11 % in the United States , where only 66 % of it was documented for therapeutic use .
12-1	1603-1606	The	abstract[80]	new[80]	_	_
12-2	1607-1617	prevalence	abstract[80]	new[80]	_	_
12-3	1618-1620	of	abstract[80]	new[80]	_	_
12-4	1621-1634	antimicrobial	abstract[80]|abstract[81]	new[80]|giv[81]	ana	12-25[0_81]
12-5	1635-1646	consumption	abstract[80]|abstract[81]	new[80]|giv[81]	_	_
12-6	1647-1649	in	abstract[80]|abstract[81]	new[80]|giv[81]	_	_
12-7	1650-1657	nursing	abstract[80]|abstract[81]|place[82]	new[80]|giv[81]|giv[82]	_	_
12-8	1658-1663	homes	abstract[80]|abstract[81]|place[82]	new[80]|giv[81]|giv[82]	_	_
12-9	1664-1667	was	_	_	_	_
12-10	1668-1676	reported	_	_	_	_
12-11	1677-1679	to	_	_	_	_
12-12	1680-1682	be	_	_	_	_
12-13	1683-1685	11	quantity[83]	giv[83]	_	_
12-14	1686-1687	%	quantity[83]	giv[83]	_	_
12-15	1688-1690	in	quantity[83]	giv[83]	_	_
12-16	1691-1694	the	quantity[83]|place[84]	giv[83]|giv[84]	_	_
12-17	1695-1701	United	quantity[83]|place[84]	giv[83]|giv[84]	_	_
12-18	1702-1708	States	quantity[83]|place[84]	giv[83]|giv[84]	_	_
12-19	1709-1710	,	_	_	_	_
12-20	1711-1716	where	_	_	_	_
12-21	1717-1721	only	quantity[85]	new[85]	_	_
12-22	1722-1724	66	quantity[85]	new[85]	_	_
12-23	1725-1726	%	quantity[85]	new[85]	_	_
12-24	1727-1729	of	quantity[85]	new[85]	_	_
12-25	1730-1732	it	quantity[85]|abstract	new[85]|giv	_	_
12-26	1733-1736	was	_	_	_	_
12-27	1737-1747	documented	_	_	_	_
12-28	1748-1751	for	_	_	_	_
12-29	1752-1763	therapeutic	abstract[87]	giv[87]	coref	17-6[125_87]
12-30	1764-1767	use	abstract[87]	giv[87]	_	_
12-31	1768-1769	.	_	_	_	_

#Text=The reported incidence of infections was higher in the older adult population because of the presence of chronic comorbidities , deteriorating organ functions and reduced host defence system .
13-1	1770-1773	The	abstract[88]	new[88]	_	_
13-2	1774-1782	reported	abstract[88]	new[88]	_	_
13-3	1783-1792	incidence	abstract[88]	new[88]	_	_
13-4	1793-1795	of	abstract[88]	new[88]	_	_
13-5	1796-1806	infections	abstract[88]|abstract	new[88]|giv	coref	14-11[100_0]
13-6	1807-1810	was	_	_	_	_
13-7	1811-1817	higher	_	_	_	_
13-8	1818-1820	in	_	_	_	_
13-9	1821-1824	the	person[90]	giv[90]	coref	28-16[225_90]
13-10	1825-1830	older	person[90]	giv[90]	_	_
13-11	1831-1836	adult	person[90]	giv[90]	_	_
13-12	1837-1847	population	person[90]	giv[90]	_	_
13-13	1848-1855	because	_	_	_	_
13-14	1856-1858	of	_	_	_	_
13-15	1859-1862	the	abstract[91]	new[91]	_	_
13-16	1863-1871	presence	abstract[91]	new[91]	_	_
13-17	1872-1874	of	abstract[91]	new[91]	_	_
13-18	1875-1882	chronic	abstract[91]|abstract[92]	new[91]|new[92]	_	_
13-19	1883-1896	comorbidities	abstract[91]|abstract[92]	new[91]|new[92]	_	_
13-20	1897-1898	,	_	_	_	_
13-21	1899-1912	deteriorating	_	_	_	_
13-22	1913-1918	organ	abstract|abstract[94]	new|new[94]	_	_
13-23	1919-1928	functions	abstract[94]	new[94]	_	_
13-24	1929-1932	and	_	_	_	_
13-25	1933-1940	reduced	abstract[97]	new[97]	_	_
13-26	1941-1945	host	person|abstract[97]	new|new[97]	_	_
13-27	1946-1953	defence	abstract|abstract[97]	new|new[97]	_	_
13-28	1954-1960	system	abstract[97]	new[97]	_	_
13-29	1961-1962	.	_	_	_	_

#Text=Older adults also have poorer outcomes as a consequence of infections , including higher mortality , compared to adults of other age groups .
14-1	1963-1968	Older	person[98]	giv[98]	coref	14-19[102_98]
14-2	1969-1975	adults	person[98]	giv[98]	_	_
14-3	1976-1980	also	_	_	_	_
14-4	1981-1985	have	_	_	_	_
14-5	1986-1992	poorer	abstract[99]	new[99]	coref	15-27[115_99]
14-6	1993-2001	outcomes	abstract[99]	new[99]	_	_
14-7	2002-2004	as	abstract[99]	new[99]	_	_
14-8	2005-2006	a	abstract[99]	new[99]	_	_
14-9	2007-2018	consequence	abstract[99]	new[99]	_	_
14-10	2019-2021	of	abstract[99]	new[99]	_	_
14-11	2022-2032	infections	abstract[99]|abstract[100]	new[99]|giv[100]	coref	15-5[106_100]
14-12	2033-2034	,	abstract[99]|abstract[100]	new[99]|giv[100]	_	_
14-13	2035-2044	including	abstract[99]|abstract[100]	new[99]|giv[100]	_	_
14-14	2045-2051	higher	abstract[99]|abstract[100]|event[101]	new[99]|giv[100]|giv[101]	_	_
14-15	2052-2061	mortality	abstract[99]|abstract[100]|event[101]	new[99]|giv[100]|giv[101]	_	_
14-16	2062-2063	,	_	_	_	_
14-17	2064-2072	compared	_	_	_	_
14-18	2073-2075	to	_	_	_	_
14-19	2076-2082	adults	person[102]	giv[102]	coref	16-3[116_102]
14-20	2083-2085	of	person[102]	giv[102]	_	_
14-21	2086-2091	other	person[102]|person[104]	giv[102]|new[104]	coref	27-28[218_104]
14-22	2092-2095	age	person[102]|abstract|person[104]	giv[102]|new|new[104]	_	_
14-23	2096-2102	groups	person[102]|person[104]	giv[102]|new[104]	_	_
14-24	2103-2104	.	_	_	_	_

#Text=Atypical clinical presentations of infections , undertreatment or overtreatment , high risk of multidrug-resistant organism acquisition , rapid disease progression and prolonged recovery all contribute to poorer outcomes in the elderly .
15-1	2105-2113	Atypical	abstract[105]	new[105]	_	_
15-2	2114-2122	clinical	abstract[105]	new[105]	_	_
15-3	2123-2136	presentations	abstract[105]	new[105]	_	_
15-4	2137-2139	of	abstract[105]	new[105]	_	_
15-5	2140-2150	infections	abstract[105]|abstract[106]	new[105]|giv[106]	coref	17-30[131_106]
15-6	2151-2152	,	abstract[105]|abstract[106]	new[105]|giv[106]	_	_
15-7	2153-2167	undertreatment	abstract[105]|abstract[106]|abstract	new[105]|giv[106]|new	_	_
15-8	2168-2170	or	abstract[105]|abstract[106]	new[105]|giv[106]	_	_
15-9	2171-2184	overtreatment	abstract[105]|abstract[106]|event	new[105]|giv[106]|new	_	_
15-10	2185-2186	,	abstract[105]|abstract[106]	new[105]|giv[106]	_	_
15-11	2187-2191	high	abstract[105]|abstract[106]|abstract[109]	new[105]|giv[106]|new[109]	_	_
15-12	2192-2196	risk	abstract[105]|abstract[106]|abstract[109]	new[105]|giv[106]|new[109]	_	_
15-13	2197-2199	of	abstract[105]|abstract[106]|abstract[109]	new[105]|giv[106]|new[109]	_	_
15-14	2200-2219	multidrug-resistant	abstract[105]|abstract[106]|abstract[109]|event[111]	new[105]|giv[106]|new[109]|new[111]	_	_
15-15	2220-2228	organism	abstract[105]|abstract[106]|abstract[109]|abstract|event[111]	new[105]|giv[106]|new[109]|new|new[111]	_	_
15-16	2229-2240	acquisition	abstract[105]|abstract[106]|abstract[109]|event[111]	new[105]|giv[106]|new[109]|new[111]	_	_
15-17	2241-2242	,	abstract[105]|abstract[106]|abstract[109]	new[105]|giv[106]|new[109]	_	_
15-18	2243-2248	rapid	abstract[105]|abstract[106]|abstract[109]|abstract[113]	new[105]|giv[106]|new[109]|new[113]	_	_
15-19	2249-2256	disease	abstract[105]|abstract[106]|abstract[109]|abstract|abstract[113]	new[105]|giv[106]|new[109]|new|new[113]	_	_
15-20	2257-2268	progression	abstract[105]|abstract[106]|abstract[109]|abstract[113]	new[105]|giv[106]|new[109]|new[113]	_	_
15-21	2269-2272	and	abstract[105]|abstract[106]|abstract[109]	new[105]|giv[106]|new[109]	_	_
15-22	2273-2282	prolonged	abstract[105]|abstract[106]|abstract[109]|event[114]	new[105]|giv[106]|new[109]|new[114]	coref	26-31[207_114]
15-23	2283-2291	recovery	abstract[105]|abstract[106]|abstract[109]|event[114]	new[105]|giv[106]|new[109]|new[114]	_	_
15-24	2292-2295	all	_	_	_	_
15-25	2296-2306	contribute	_	_	_	_
15-26	2307-2309	to	_	_	_	_
15-27	2310-2316	poorer	abstract[115]	giv[115]	_	_
15-28	2317-2325	outcomes	abstract[115]	giv[115]	_	_
15-29	2326-2328	in	_	_	_	_
15-30	2329-2332	the	_	_	_	_
15-31	2333-2340	elderly	_	_	_	_
15-32	2341-2342	.	_	_	_	_

#Text=Moreover , older adults who were living alone have lower health literacy and hence lower self-management abilities , contributing to poorer health .
16-1	2343-2351	Moreover	_	_	_	_
16-2	2352-2353	,	_	_	_	_
16-3	2354-2359	older	person[116]	giv[116]	ana	17-21[0_116]
16-4	2360-2366	adults	person[116]	giv[116]	_	_
16-5	2367-2370	who	_	_	_	_
16-6	2371-2375	were	_	_	_	_
16-7	2376-2382	living	_	_	_	_
16-8	2383-2388	alone	_	_	_	_
16-9	2389-2393	have	_	_	_	_
16-10	2394-2399	lower	abstract[118]	new[118]	_	_
16-11	2400-2406	health	abstract|abstract[118]	giv|new[118]	coref	16-21[121_0]
16-12	2407-2415	literacy	abstract[118]	new[118]	_	_
16-13	2416-2419	and	_	_	_	_
16-14	2420-2425	hence	abstract[120]	new[120]	_	_
16-15	2426-2431	lower	abstract[120]	new[120]	_	_
16-16	2432-2447	self-management	abstract|abstract[120]	new|new[120]	_	_
16-17	2448-2457	abilities	abstract[120]	new[120]	_	_
16-18	2458-2459	,	_	_	_	_
16-19	2460-2472	contributing	_	_	_	_
16-20	2473-2475	to	_	_	_	_
16-21	2476-2482	poorer	abstract[121]	giv[121]	_	_
16-22	2483-2489	health	abstract[121]	giv[121]	_	_
16-23	2490-2491	.	_	_	_	_

#Text=A lack of knowledge on antibiotic use in the general public has been reported , with more than half of them who thought that antibiotics are useful in treating viral infections , and about one half of them would stop taking antibiotics when they felt better .
17-1	2492-2493	A	abstract[122]	new[122]	_	_
17-2	2494-2498	lack	abstract[122]	new[122]	_	_
17-3	2499-2501	of	abstract[122]	new[122]	_	_
17-4	2502-2511	knowledge	abstract[122]|abstract[123]	new[122]|new[123]	coref	19-4[143_123]
17-5	2512-2514	on	abstract[122]|abstract[123]	new[122]|new[123]	_	_
17-6	2515-2525	antibiotic	abstract[122]|abstract[123]|substance|abstract[125]	new[122]|new[123]|giv|giv[125]	coref|coref|coref|coref	18-6|19-7[145_125]|18-6|19-7[145_125]
17-7	2526-2529	use	abstract[122]|abstract[123]|abstract[125]	new[122]|new[123]|giv[125]	_	_
17-8	2530-2532	in	abstract[122]|abstract[123]|abstract[125]	new[122]|new[123]|giv[125]	_	_
17-9	2533-2536	the	abstract[122]|abstract[123]|abstract[125]|person[126]	new[122]|new[123]|giv[125]|new[126]	_	_
17-10	2537-2544	general	abstract[122]|abstract[123]|abstract[125]|person[126]	new[122]|new[123]|giv[125]|new[126]	_	_
17-11	2545-2551	public	abstract[122]|abstract[123]|abstract[125]|person[126]	new[122]|new[123]|giv[125]|new[126]	_	_
17-12	2552-2555	has	_	_	_	_
17-13	2556-2560	been	_	_	_	_
17-14	2561-2569	reported	_	_	_	_
17-15	2570-2571	,	_	_	_	_
17-16	2572-2576	with	_	_	_	_
17-17	2577-2581	more	_	_	_	_
17-18	2582-2586	than	_	_	_	_
17-19	2587-2591	half	quantity[127]	new[127]	_	_
17-20	2592-2594	of	quantity[127]	new[127]	_	_
17-21	2595-2599	them	quantity[127]|person	new[127]|giv	ana	17-38
17-22	2600-2603	who	_	_	_	_
17-23	2604-2611	thought	_	_	_	_
17-24	2612-2616	that	_	_	_	_
17-25	2617-2628	antibiotics	substance	new	coref	17-42
17-26	2629-2632	are	_	_	_	_
17-27	2633-2639	useful	_	_	_	_
17-28	2640-2642	in	_	_	_	_
17-29	2643-2651	treating	_	_	_	_
17-30	2652-2657	viral	object|abstract[131]	new|giv[131]	coref|coref	24-14[190_131]|24-14[190_131]
17-31	2658-2668	infections	abstract[131]	giv[131]	_	_
17-32	2669-2670	,	_	_	_	_
17-33	2671-2674	and	_	_	_	_
17-34	2675-2680	about	quantity[132]	new[132]	_	_
17-35	2681-2684	one	quantity[132]	new[132]	_	_
17-36	2685-2689	half	quantity[132]	new[132]	_	_
17-37	2690-2692	of	quantity[132]	new[132]	_	_
17-38	2693-2697	them	quantity[132]|person	new[132]|giv	ana	17-44
17-39	2698-2703	would	_	_	_	_
17-40	2704-2708	stop	_	_	_	_
17-41	2709-2715	taking	_	_	_	_
17-42	2716-2727	antibiotics	substance	giv	coref	18-13
17-43	2728-2732	when	_	_	_	_
17-44	2733-2737	they	person	giv	ana	18-1
17-45	2738-2742	felt	_	_	_	_
17-46	2743-2749	better	_	_	_	_
17-47	2750-2751	.	_	_	_	_

#Text=Those who were aware of antibiotic resistance were unaware that misuse of antibiotics could lead to this global crisis .
18-1	2752-2757	Those	person	giv	ana	19-1
18-2	2758-2761	who	_	_	_	_
18-3	2762-2766	were	_	_	_	_
18-4	2767-2772	aware	_	_	_	_
18-5	2773-2775	of	_	_	_	_
18-6	2776-2786	antibiotic	substance|abstract[138]	giv|giv[138]	coref|coref|coref|coref	19-7|22-19[177_138]|19-7|22-19[177_138]
18-7	2787-2797	resistance	abstract[138]	giv[138]	_	_
18-8	2798-2802	were	_	_	_	_
18-9	2803-2810	unaware	_	_	_	_
18-10	2811-2815	that	_	_	_	_
18-11	2816-2822	misuse	abstract[139]	new[139]	_	_
18-12	2823-2825	of	abstract[139]	new[139]	_	_
18-13	2826-2837	antibiotics	abstract[139]|substance	new[139]|giv	coref	19-22[150_0]
18-14	2838-2843	could	_	_	_	_
18-15	2844-2848	lead	_	_	_	_
18-16	2849-2851	to	_	_	_	_
18-17	2852-2856	this	abstract[141]	giv[141]	_	_
18-18	2857-2863	global	abstract[141]	giv[141]	_	_
18-19	2864-2870	crisis	abstract[141]	giv[141]	_	_
18-20	2871-2872	.	_	_	_	_

#Text=Those who had poor knowledge of antibiotic use were associated with a higher probability of antibiotic self-medication and practices of using leftover antibiotics , sharing antibiotics , keeping antibiotics for future use and stopping antibiotics when symptoms disappear .
19-1	2873-2878	Those	person	giv	coref	20-16[159_0]
19-2	2879-2882	who	_	_	_	_
19-3	2883-2886	had	_	_	_	_
19-4	2887-2891	poor	abstract[143]	giv[143]	_	_
19-5	2892-2901	knowledge	abstract[143]	giv[143]	_	_
19-6	2902-2904	of	abstract[143]	giv[143]	_	_
19-7	2905-2915	antibiotic	abstract[143]|substance|abstract[145]	giv[143]|giv|giv[145]	coref|coref|coref|coref	19-16|19-31[153_145]|19-16|19-31[153_145]
19-8	2916-2919	use	abstract[143]|abstract[145]	giv[143]|giv[145]	_	_
19-9	2920-2924	were	_	_	_	_
19-10	2925-2935	associated	_	_	_	_
19-11	2936-2940	with	_	_	_	_
19-12	2941-2942	a	abstract[146]	new[146]	_	_
19-13	2943-2949	higher	abstract[146]	new[146]	_	_
19-14	2950-2961	probability	abstract[146]	new[146]	_	_
19-15	2962-2964	of	abstract[146]	new[146]	_	_
19-16	2965-2975	antibiotic	abstract[146]|substance|abstract[148]	new[146]|giv|new[148]	coref|coref|coref|coref	20-8[0_148]|21-17|20-8[0_148]|21-17
19-17	2976-2991	self-medication	abstract[146]|abstract[148]	new[146]|new[148]	_	_
19-18	2992-2995	and	abstract[146]	new[146]	_	_
19-19	2996-3005	practices	abstract[146]|abstract	new[146]|new	coref	20-1[156_0]
19-20	3006-3008	of	_	_	_	_
19-21	3009-3014	using	_	_	_	_
19-22	3015-3023	leftover	substance[150]	giv[150]	coref	19-26[0_150]
19-23	3024-3035	antibiotics	substance[150]	giv[150]	_	_
19-24	3036-3037	,	_	_	_	_
19-25	3038-3045	sharing	_	_	_	_
19-26	3046-3057	antibiotics	substance	giv	coref	19-29[152_0]
19-27	3058-3059	,	_	_	_	_
19-28	3060-3067	keeping	_	_	_	_
19-29	3068-3079	antibiotics	substance[152]	giv[152]	coref	19-35[0_152]
19-30	3080-3083	for	substance[152]	giv[152]	_	_
19-31	3084-3090	future	substance[152]|abstract[153]	giv[152]|giv[153]	coref	21-17[165_153]
19-32	3091-3094	use	substance[152]|abstract[153]	giv[152]|giv[153]	_	_
19-33	3095-3098	and	_	_	_	_
19-34	3099-3107	stopping	_	_	_	_
19-35	3108-3119	antibiotics	substance	giv	coref	20-5[157_0]
19-36	3120-3124	when	_	_	_	_
19-37	3125-3133	symptoms	abstract	new	_	_
19-38	3134-3143	disappear	_	_	_	_
19-39	3144-3145	.	_	_	_	_

#Text=Inappropriate practices related to antibiotics , including self-medication , were reported to be common among older adults .
20-1	3146-3159	Inappropriate	abstract[156]	giv[156]	coref	29-14[0_156]
20-2	3160-3169	practices	abstract[156]	giv[156]	_	_
20-3	3170-3177	related	_	_	_	_
20-4	3178-3180	to	_	_	_	_
20-5	3181-3192	antibiotics	substance[157]	giv[157]	coref	21-31[0_157]
20-6	3193-3194	,	substance[157]	giv[157]	_	_
20-7	3195-3204	including	substance[157]	giv[157]	_	_
20-8	3205-3220	self-medication	substance[157]|abstract	giv[157]|giv	_	_
20-9	3221-3222	,	_	_	_	_
20-10	3223-3227	were	_	_	_	_
20-11	3228-3236	reported	_	_	_	_
20-12	3237-3239	to	_	_	_	_
20-13	3240-3242	be	_	_	_	_
20-14	3243-3249	common	_	_	_	_
20-15	3250-3255	among	_	_	_	_
20-16	3256-3261	older	person[159]	giv[159]	coref	21-9[162_159]
20-17	3262-3268	adults	person[159]	giv[159]	_	_
20-18	3269-3270	.	_	_	_	_

#Text=In one study , a considerable proportion of older adults ( 77.8 % ) who had antibiotic use within the past six months were found to have experience of receiving antibiotics without prescriptions .
21-1	3271-3273	In	_	_	_	_
21-2	3274-3277	one	abstract[160]	new[160]	coref	28-13[224_160]
21-3	3278-3283	study	abstract[160]	new[160]	_	_
21-4	3284-3285	,	_	_	_	_
21-5	3286-3287	a	quantity[161]	new[161]	_	_
21-6	3288-3300	considerable	quantity[161]	new[161]	_	_
21-7	3301-3311	proportion	quantity[161]	new[161]	_	_
21-8	3312-3314	of	quantity[161]	new[161]	_	_
21-9	3315-3320	older	quantity[161]|person[162]	new[161]|giv[162]	coref	22-21[178_162]
21-10	3321-3327	adults	quantity[161]|person[162]	new[161]|giv[162]	_	_
21-11	3328-3329	(	_	_	_	_
21-12	3330-3334	77.8	quantity[163]	new[163]	_	_
21-13	3335-3336	%	quantity[163]	new[163]	_	_
21-14	3337-3338	)	_	_	_	_
21-15	3339-3342	who	_	_	_	_
21-16	3343-3346	had	_	_	_	_
21-17	3347-3357	antibiotic	substance|abstract[165]	giv|giv[165]	coref|coref|coref|coref	22-16|22-16[175_165]|22-16|22-16[175_165]
21-18	3358-3361	use	abstract[165]	giv[165]	_	_
21-19	3362-3368	within	_	_	_	_
21-20	3369-3372	the	time[166]	new[166]	_	_
21-21	3373-3377	past	time[166]	new[166]	_	_
21-22	3378-3381	six	time[166]	new[166]	_	_
21-23	3382-3388	months	time[166]	new[166]	_	_
21-24	3389-3393	were	_	_	_	_
21-25	3394-3399	found	_	_	_	_
21-26	3400-3402	to	_	_	_	_
21-27	3403-3407	have	_	_	_	_
21-28	3408-3418	experience	abstract	new	_	_
21-29	3419-3421	of	_	_	_	_
21-30	3422-3431	receiving	_	_	_	_
21-31	3432-3443	antibiotics	substance	giv	coref	23-18
21-32	3444-3451	without	_	_	_	_
21-33	3452-3465	prescriptions	abstract	giv	_	_
21-34	3466-3467	.	_	_	_	_

#Text=However , only a few studies reported the lack of knowledge and poor attitude on antibiotic use and resistance among older adults .
22-1	3468-3475	However	_	_	_	_
22-2	3476-3477	,	_	_	_	_
22-3	3478-3482	only	event[170]	new[170]	_	_
22-4	3483-3484	a	event[170]	new[170]	_	_
22-5	3485-3488	few	event[170]	new[170]	_	_
22-6	3489-3496	studies	event[170]	new[170]	_	_
22-7	3497-3505	reported	_	_	_	_
22-8	3506-3509	the	abstract[171]	new[171]	_	_
22-9	3510-3514	lack	abstract[171]	new[171]	_	_
22-10	3515-3517	of	abstract[171]	new[171]	_	_
22-11	3518-3527	knowledge	abstract[171]|abstract	new[171]|new	coref	27-2[209_0]
22-12	3528-3531	and	abstract[171]	new[171]	_	_
22-13	3532-3536	poor	abstract[171]|abstract[173]	new[171]|new[173]	_	_
22-14	3537-3545	attitude	abstract[171]|abstract[173]	new[171]|new[173]	_	_
22-15	3546-3548	on	abstract[171]|abstract[173]	new[171]|new[173]	_	_
22-16	3549-3559	antibiotic	abstract[171]|abstract[173]|substance|abstract[175]|abstract[176]	new[171]|new[173]|giv|giv[175]|new[176]	coref|coref|coref|coref|coref|coref|coref|coref|coref	23-9|27-15[213_175]|27-15[214_176]|23-9|27-15[213_175]|27-15[214_176]|23-9|27-15[213_175]|27-15[214_176]
22-17	3560-3563	use	abstract[171]|abstract[173]|abstract[175]|abstract[176]	new[171]|new[173]|giv[175]|new[176]	_	_
22-18	3564-3567	and	abstract[171]|abstract[173]|abstract[176]	new[171]|new[173]|new[176]	_	_
22-19	3568-3578	resistance	abstract[171]|abstract[173]|abstract[176]|abstract[177]	new[171]|new[173]|new[176]|giv[177]	coref	27-18[0_177]
22-20	3579-3584	among	abstract[171]|abstract[173]|abstract[176]|abstract[177]	new[171]|new[173]|new[176]|giv[177]	_	_
22-21	3585-3590	older	abstract[171]|abstract[173]|abstract[176]|abstract[177]|person[178]	new[171]|new[173]|new[176]|giv[177]|giv[178]	coref	26-10[202_178]
22-22	3591-3597	adults	abstract[171]|abstract[173]|abstract[176]|abstract[177]|person[178]	new[171]|new[173]|new[176]|giv[177]|giv[178]	_	_
22-23	3598-3599	.	_	_	_	_

#Text=Patients who were unaware of the consequences of antibiotic overuse to the community were found to expect antibiotics from their prescriber .
23-1	3600-3608	Patients	person	new	ana	23-20
23-2	3609-3612	who	_	_	_	_
23-3	3613-3617	were	_	_	_	_
23-4	3618-3625	unaware	_	_	_	_
23-5	3626-3628	of	_	_	_	_
23-6	3629-3632	the	abstract[180]	new[180]	_	_
23-7	3633-3645	consequences	abstract[180]	new[180]	_	_
23-8	3646-3648	of	abstract[180]	new[180]	_	_
23-9	3649-3659	antibiotic	abstract[180]|substance|abstract[182]	new[180]|giv|giv[182]	coref|coref	25-14|25-14
23-10	3660-3667	overuse	abstract[180]|abstract[182]	new[180]|giv[182]	_	_
23-11	3668-3670	to	abstract[180]|abstract[182]	new[180]|giv[182]	_	_
23-12	3671-3674	the	abstract[180]|abstract[182]|organization[183]	new[180]|giv[182]|new[183]	_	_
23-13	3675-3684	community	abstract[180]|abstract[182]|organization[183]	new[180]|giv[182]|new[183]	_	_
23-14	3685-3689	were	_	_	_	_
23-15	3690-3695	found	_	_	_	_
23-16	3696-3698	to	_	_	_	_
23-17	3699-3705	expect	_	_	_	_
23-18	3706-3717	antibiotics	substance	giv	coref	24-10
23-19	3718-3722	from	_	_	_	_
23-20	3723-3728	their	person|object[186]	giv|new[186]	ana|ana	24-5|24-5
23-21	3729-3739	prescriber	object[186]	new[186]	_	_
23-22	3740-3741	.	_	_	_	_

#Text=Studies have found that those who incorrectly believed that antibiotics will work for viral infections were more likely to expect antibiotics from prescribers .
24-1	3742-3749	Studies	abstract	new	coref	27-5[210_0]
24-2	3750-3754	have	_	_	_	_
24-3	3755-3760	found	_	_	_	_
24-4	3761-3765	that	_	_	_	_
24-5	3766-3771	those	person	giv	coref	25-1[193_0]
24-6	3772-3775	who	_	_	_	_
24-7	3776-3787	incorrectly	_	_	_	_
24-8	3788-3796	believed	_	_	_	_
24-9	3797-3801	that	_	_	_	_
24-10	3802-3813	antibiotics	substance	giv	coref	24-21
24-11	3814-3818	will	_	_	_	_
24-12	3819-3823	work	_	_	_	_
24-13	3824-3827	for	_	_	_	_
24-14	3828-3833	viral	abstract[190]	giv[190]	_	_
24-15	3834-3844	infections	abstract[190]	giv[190]	_	_
24-16	3845-3849	were	_	_	_	_
24-17	3850-3854	more	_	_	_	_
24-18	3855-3861	likely	_	_	_	_
24-19	3862-3864	to	_	_	_	_
24-20	3865-3871	expect	_	_	_	_
24-21	3872-3883	antibiotics	substance	giv	coref	25-5
24-22	3884-3888	from	_	_	_	_
24-23	3889-3900	prescribers	person	new	_	_
24-24	3901-3902	.	_	_	_	_

#Text=Patients â€™ expectations of antibiotics are found to be an important predictor of antibiotic prescribing .
25-1	3903-3911	Patients	person[193]|abstract[194]	giv[193]|new[194]	coref|coref	26-1[199_194]|26-1[199_194]
25-2	3912-3913	â€™	person[193]|abstract[194]	giv[193]|new[194]	_	_
25-3	3914-3926	expectations	abstract[194]	new[194]	_	_
25-4	3927-3929	of	abstract[194]	new[194]	_	_
25-5	3930-3941	antibiotics	abstract[194]|substance	new[194]|giv	coref	26-3[200_0]
25-6	3942-3945	are	_	_	_	_
25-7	3946-3951	found	_	_	_	_
25-8	3952-3954	to	_	_	_	_
25-9	3955-3957	be	_	_	_	_
25-10	3958-3960	an	abstract[196]	new[196]	_	_
25-11	3961-3970	important	abstract[196]	new[196]	_	_
25-12	3971-3980	predictor	abstract[196]	new[196]	_	_
25-13	3981-3983	of	abstract[196]	new[196]	_	_
25-14	3984-3994	antibiotic	abstract[196]|substance|abstract[198]	new[196]|giv|new[198]	coref|coref	27-15|27-15
25-15	3995-4006	prescribing	abstract[196]|abstract[198]	new[196]|new[198]	_	_
25-16	4007-4008	.	_	_	_	_

#Text=Expectations for antibiotics for common cold were found among older adults when they felt sick enough to visit a physician , although most of them disagreed that antibiotics could speed the recovery .
26-1	4009-4021	Expectations	abstract[199]	giv[199]	coref	28-32[234_199]
26-2	4022-4025	for	abstract[199]	giv[199]	_	_
26-3	4026-4037	antibiotics	abstract[199]|substance[200]	giv[199]|giv[200]	coref	26-28[0_200]
26-4	4038-4041	for	abstract[199]|substance[200]	giv[199]|giv[200]	_	_
26-5	4042-4048	common	abstract[199]|substance[200]|abstract[201]	giv[199]|giv[200]|new[201]	_	_
26-6	4049-4053	cold	abstract[199]|substance[200]|abstract[201]	giv[199]|giv[200]|new[201]	_	_
26-7	4054-4058	were	_	_	_	_
26-8	4059-4064	found	_	_	_	_
26-9	4065-4070	among	_	_	_	_
26-10	4071-4076	older	person[202]	giv[202]	ana	26-13[0_202]
26-11	4077-4083	adults	person[202]	giv[202]	_	_
26-12	4084-4088	when	_	_	_	_
26-13	4089-4093	they	person	giv	ana	26-25
26-14	4094-4098	felt	_	_	_	_
26-15	4099-4103	sick	_	_	_	_
26-16	4104-4110	enough	_	_	_	_
26-17	4111-4113	to	_	_	_	_
26-18	4114-4119	visit	_	_	_	_
26-19	4120-4121	a	person[204]	new[204]	_	_
26-20	4122-4131	physician	person[204]	new[204]	_	_
26-21	4132-4133	,	_	_	_	_
26-22	4134-4142	although	_	_	_	_
26-23	4143-4147	most	_	_	_	_
26-24	4148-4150	of	_	_	_	_
26-25	4151-4155	them	person	giv	coref	27-33[219_0]
26-26	4156-4165	disagreed	_	_	_	_
26-27	4166-4170	that	_	_	_	_
26-28	4171-4182	antibiotics	substance	giv	coref	28-38
26-29	4183-4188	could	_	_	_	_
26-30	4189-4194	speed	_	_	_	_
26-31	4195-4198	the	event[207]	giv[207]	_	_
26-32	4199-4207	recovery	event[207]	giv[207]	_	_
26-33	4208-4209	.	_	_	_	_

#Text=To our knowledge , many studies have been done to assess the knowledge of antibiotic use and resistance ; however , there has been limited research targeting vulnerable population groups , including older adults .
27-1	4210-4212	To	_	_	_	_
27-2	4213-4216	our	person|abstract[209]	acc|giv[209]	ana|ana	28-11|28-11
27-3	4217-4226	knowledge	abstract[209]	giv[209]	_	_
27-4	4227-4228	,	_	_	_	_
27-5	4229-4233	many	abstract[210]	giv[210]	_	_
27-6	4234-4241	studies	abstract[210]	giv[210]	_	_
27-7	4242-4246	have	_	_	_	_
27-8	4247-4251	been	_	_	_	_
27-9	4252-4256	done	_	_	_	_
27-10	4257-4259	to	_	_	_	_
27-11	4260-4266	assess	_	_	_	_
27-12	4267-4270	the	abstract[211]	new[211]	coref	28-24[228_211]
27-13	4271-4280	knowledge	abstract[211]	new[211]	_	_
27-14	4281-4283	of	abstract[211]	new[211]	_	_
27-15	4284-4294	antibiotic	abstract[211]|substance|abstract[213]|abstract[214]	new[211]|giv|giv[213]|giv[214]	ana|coref|coref|ana|coref|coref|ana|coref|coref	28-24[0_214]|28-27|28-27[230_213]|28-24[0_214]|28-27|28-27[230_213]|28-24[0_214]|28-27|28-27[230_213]
27-16	4295-4298	use	abstract[211]|abstract[213]|abstract[214]	new[211]|giv[213]|giv[214]	_	_
27-17	4299-4302	and	abstract[211]|abstract[214]	new[211]|giv[214]	_	_
27-18	4303-4313	resistance	abstract[211]|abstract[214]|abstract	new[211]|giv[214]|giv	coref	28-30
27-19	4314-4315	;	_	_	_	_
27-20	4316-4323	however	_	_	_	_
27-21	4324-4325	,	_	_	_	_
27-22	4326-4331	there	_	_	_	_
27-23	4332-4335	has	_	_	_	_
27-24	4336-4340	been	_	_	_	_
27-25	4341-4348	limited	abstract[216]	new[216]	_	_
27-26	4349-4357	research	abstract[216]	new[216]	_	_
27-27	4358-4367	targeting	_	_	_	_
27-28	4368-4378	vulnerable	person[218]	giv[218]	_	_
27-29	4379-4389	population	abstract|person[218]	new|giv[218]	_	_
27-30	4390-4396	groups	person[218]	giv[218]	_	_
27-31	4397-4398	,	person[218]	giv[218]	_	_
27-32	4399-4408	including	person[218]	giv[218]	_	_
27-33	4409-4414	older	person[218]|person[219]	giv[218]|giv[219]	coref	29-20[243_219]
27-34	4415-4421	adults	person[218]|person[219]	giv[218]|giv[219]	_	_
27-35	4422-4423	.	_	_	_	_

#Text=Due to the paucity of information in this area , we conducted a study among the older adult population in Malaysia to assess their knowledge on antibiotic use and resistance and their expectations towards the need for antibiotics .
28-1	4424-4427	Due	_	_	_	_
28-2	4428-4430	to	_	_	_	_
28-3	4431-4434	the	abstract[220]	new[220]	_	_
28-4	4435-4442	paucity	abstract[220]	new[220]	_	_
28-5	4443-4445	of	abstract[220]	new[220]	_	_
28-6	4446-4457	information	abstract[220]|abstract	new[220]|new	_	_
28-7	4458-4460	in	abstract[220]	new[220]	_	_
28-8	4461-4465	this	abstract[220]|abstract[222]	new[220]|new[222]	_	_
28-9	4466-4470	area	abstract[220]|abstract[222]	new[220]|new[222]	_	_
28-10	4471-4472	,	_	_	_	_
28-11	4473-4475	we	person	giv	_	_
28-12	4476-4485	conducted	_	_	_	_
28-13	4486-4487	a	abstract[224]	giv[224]	coref	29-1[237_224]
28-14	4488-4493	study	abstract[224]	giv[224]	_	_
28-15	4494-4499	among	abstract[224]	giv[224]	_	_
28-16	4500-4503	the	abstract[224]|person[225]	giv[224]|giv[225]	_	_
28-17	4504-4509	older	abstract[224]|person[225]	giv[224]|giv[225]	_	_
28-18	4510-4515	adult	abstract[224]|person[225]	giv[224]|giv[225]	_	_
28-19	4516-4526	population	abstract[224]|person[225]	giv[224]|giv[225]	_	_
28-20	4527-4529	in	abstract[224]|person[225]	giv[224]|giv[225]	_	_
28-21	4530-4538	Malaysia	abstract[224]|person[225]|place	giv[224]|giv[225]|giv	_	_
28-22	4539-4541	to	_	_	_	_
28-23	4542-4548	assess	_	_	_	_
28-24	4549-4554	their	abstract|abstract[228]	giv|giv[228]	ana|coref|ana|coref	28-32|29-10[0_228]|28-32|29-10[0_228]
28-25	4555-4564	knowledge	abstract[228]	giv[228]	_	_
28-26	4565-4567	on	abstract[228]	giv[228]	_	_
28-27	4568-4578	antibiotic	abstract[228]|substance|abstract[230]|abstract[231]	giv[228]|giv|giv[230]|giv[231]	coref|coref|coref	29-17|29-17|29-17
28-28	4579-4582	use	abstract[228]|abstract[230]|abstract[231]	giv[228]|giv[230]|giv[231]	_	_
28-29	4583-4586	and	abstract[228]|abstract[231]	giv[228]|giv[231]	_	_
28-30	4587-4597	resistance	abstract[228]|abstract[231]|abstract	giv[228]|giv[231]|giv	_	_
28-31	4598-4601	and	abstract[228]|abstract[231]	giv[228]|giv[231]	_	_
28-32	4602-4607	their	abstract[228]|abstract[231]|abstract|abstract[234]	giv[228]|giv[231]|giv|giv[234]	coref|coref	29-12[0_234]|29-12[0_234]
28-33	4608-4620	expectations	abstract[228]|abstract[231]|abstract[234]	giv[228]|giv[231]|giv[234]	_	_
28-34	4621-4628	towards	abstract[228]|abstract[231]|abstract[234]	giv[228]|giv[231]|giv[234]	_	_
28-35	4629-4632	the	abstract[228]|abstract[231]|abstract[234]|abstract[235]	giv[228]|giv[231]|giv[234]|new[235]	_	_
28-36	4633-4637	need	abstract[228]|abstract[231]|abstract[234]|abstract[235]	giv[228]|giv[231]|giv[234]|new[235]	_	_
28-37	4638-4641	for	abstract[228]|abstract[231]|abstract[234]|abstract[235]	giv[228]|giv[231]|giv[234]|new[235]	_	_
28-38	4642-4653	antibiotics	abstract[228]|abstract[231]|abstract[234]|abstract[235]|substance	giv[228]|giv[231]|giv[234]|new[235]|giv	_	_
28-39	4654-4655	.	_	_	_	_

#Text=This study also aimed to assess the relationship between knowledge , expectations and practices related to antibiotic use among older adults .
29-1	4656-4660	This	abstract[237]	giv[237]	_	_
29-2	4661-4666	study	abstract[237]	giv[237]	_	_
29-3	4667-4671	also	_	_	_	_
29-4	4672-4677	aimed	_	_	_	_
29-5	4678-4680	to	_	_	_	_
29-6	4681-4687	assess	_	_	_	_
29-7	4688-4691	the	abstract[238]	new[238]	_	_
29-8	4692-4704	relationship	abstract[238]	new[238]	_	_
29-9	4705-4712	between	abstract[238]	new[238]	_	_
29-10	4713-4722	knowledge	abstract[238]|abstract	new[238]|giv	_	_
29-11	4723-4724	,	abstract[238]	new[238]	_	_
29-12	4725-4737	expectations	abstract[238]|abstract	new[238]|giv	_	_
29-13	4738-4741	and	abstract[238]	new[238]	_	_
29-14	4742-4751	practices	abstract[238]|abstract	new[238]|giv	_	_
29-15	4752-4759	related	_	_	_	_
29-16	4760-4762	to	_	_	_	_
29-17	4763-4773	antibiotic	substance	giv	_	_
29-18	4774-4777	use	_	_	_	_
29-19	4778-4783	among	_	_	_	_
29-20	4784-4789	older	person[243]	giv[243]	_	_
29-21	4790-4796	adults	person[243]	giv[243]	_	_
29-22	4797-4798	.	_	_	_	_
